Skip to content

OWC Pharmaceutical Research Corp.

company.status.inactive

CIK 1431934fmd_0SCF485AH4H5QRRACD1M35R3ZTManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2011 to Sep 30, 2019, 32 periods

Latest annual · FY2018

Millions
Total revenues
0
Operating income
(5)
Net income
(10)

Latest quarter · Q2 FY2019

Millions
Total revenues
0
Net income
(0)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2015 to FY2018
n/m
Revenue, 5 yearsFY2013 to FY2018
n/m
Net income, 5 yearsFY2013 to FY2018
n/m

OWC Pharmaceutical Research Corp. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2018FY2017ChangeSource
Revenue$100,00010-Q 2019-05-15 · proof
Net income-$10.3 million-$4.6 million10-K 2019-04-01 · proof
Cash from operating activities-$2.5 million-$1.2 million10-K 2019-04-01 · proof
Free cash flow-$2.5 million-$1.2 million10-K 2019-04-01 · proof
What was OWC Pharmaceutical Research Corp.'s revenue in fiscal 2018?
OWC Pharmaceutical Research Corp. reported revenue of $100,000 for fiscal 2018 (the year ended Dec 31, 2018). Source: the 10-Q filed with the SEC on May 15, 2019. SEC
What was OWC Pharmaceutical Research Corp.'s net income in fiscal 2018?
OWC Pharmaceutical Research Corp. reported net income of -$10.3 million for fiscal 2018 (the year ended Dec 31, 2018), against -$4.6 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was OWC Pharmaceutical Research Corp.'s cash from operating activities in fiscal 2018?
OWC Pharmaceutical Research Corp. reported cash from operating activities of -$2.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC
What was OWC Pharmaceutical Research Corp.'s free cash flow in fiscal 2018?
OWC Pharmaceutical Research Corp. reported free cash flow of -$2.5 million for fiscal 2018 (the year ended Dec 31, 2018), against -$1.2 million the year before. Source: the 10-K filed with the SEC on Apr 1, 2019. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1431934&period_type=annual&limit=5"

Information only, not investment advice.